Upgrade to SI Premium - Free Trial

Verrica Pharmaceuticals Inc. (VRCA)

6.15 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26 *Est.)

Latest Headlines

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference May 28, 2026 8:05 AM - StreetInsider H.C. Wainwright Assumes Verrica Pharmaceuticals (VRCA) at Buy May 26, 2026 6:15 AM - StreetInsider Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ May 13, 2026 8:00 AM - Globe NewsWire Form S-8 Verrica Pharmaceuticals May 12, 2026 5:30 PM - SEC Filing Verrica Pharmaceuticals Inc. (VRCA) Misses Q1 EPS by 41c May 12, 2026 5:05 PM - StreetInsider Form 10-Q Verrica Pharmaceuticals For: Mar 31 May 12, 2026 4:16 PM - SEC Filing Form 8-K Verrica Pharmaceuticals For: May 12 May 12, 2026 4:08 PM - SEC Filing Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results May 12, 2026 4:01 PM - StreetInsider Verrica to present VP-315 basal cell carcinoma data at dermatology meeting May 5, 2026 4:06 PM - StreetInsider Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investiga May 5, 2026 4:05 PM - Globe NewsWire Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026 May 5, 2026 8:00 AM - Globe NewsWire Form ARS Verrica Pharmaceuticals For: Dec 31 April 20, 2026 4:18 PM - SEC Filing Form DEFA14A Verrica Pharmaceuticals April 20, 2026 4:16 PM - SEC Filing Form DEF 14A Verrica Pharmaceuticals For: Jun 05 April 20, 2026 4:11 PM - SEC Filing Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Inves April 9, 2026 4:05 PM - StreetInsider Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference April 6, 2026 8:00 AM - Globe NewsWire Form 10-K Verrica Pharmaceuticals For: Dec 31 March 11, 2026 8:12 AM - SEC Filing Form 8-K Verrica Pharmaceuticals For: Mar 11 March 11, 2026 8:09 AM - SEC Filing Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results March 11, 2026 8:00 AM - StreetInsider Full Article List